Liver Cancer and Risk Factors in the MENA Region: Epidemiology and Temporal Trends Based on the 2019 Global Burden of Disease Data
Open Access
- 1 January 2024
- journal article
- research article
- Published by SAGE Publications in Cancer Control
- Vol. 31
Abstract
Background: Liver cancer (LivCa) is a growing concern in the MENA region, driven by diverse factors, including viral hepatitis, lifestyle-related risks, and other causes. Methods: Utilizing GBD 2019 data, we assessed LivCa patterns, emphasizing chronic viral hepatitis, non-viral factors, and health care disparities across the MENA region. Results: Rising LivCa rates, particularly related to chronic viral hepatitis, highlight the region’s health challenges. Lifestyle factors, such as obesity and diabetes, contribute significantly. Disparities in health care access and cancer registration hinder accurate assessments. Conclusion: A comprehensive strategy is vital, encompassing vaccination promotion, health care enhancements, and lifestyle awareness. Urgent coordinated efforts are needed to address disparities, implement evidence-based interventions, and alleviate the escalating LivCa burden in the MENA region.Keywords
This publication has 42 references indexed in Scilit:
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Life, liberty, and the pursuit of healthinessThe Lancet, 2014
- Health care costs associated with hepatocellular carcinoma: A population-based studyHepatology, 2013
- Audit of state-funded antiviral treatment for chronic hepatitis C in QatarEastern Mediterranean Health Journal, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factorsHepatology, 2006
- Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in EgyptBMC Infectious Diseases, 2002
- Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalenceHepatology, 2000
- The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in EgyptThe Lancet, 2000
- High Seroprevalence of Hepatitis A, B, C, and E Viruses in Residents in an Egyptian Village in the Nile Delta: A Pilot StudyThe American Journal of Tropical Medicine and Hygiene, 1996